• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单次口服两种药物制剂后醋酸甲羟孕酮的血浆水平。

Medroxyprogesterone acetate plasma levels after a single oral administration of two drug formulations.

作者信息

Pannuti F, Strocchi E, Longhi A, Comparsi R, Camaggi C M

出版信息

Chemioterapia. 1986 Aug;5(4):237-9.

PMID:2945648
Abstract

A comparison has been made between the absorption of oral medroxyprogesterone acetate (MPA) in an aqueous suspension preparation and in syrup form. Plasma drug profiles were measured after a single administration of the two formulations in 17 advanced cancer patients. On average the standard form (aqueous suspension) gave peak levels which were lower than the syrup mixture. However, the wide intersubject spread in MPA plasma levels observed in both groups did not allow any statistical significance to be assigned to this difference.

摘要

已对醋酸甲羟孕酮(MPA)水悬浮制剂和糖浆剂的口服吸收情况进行了比较。在17例晚期癌症患者中单次给予这两种制剂后测量了血浆药物浓度曲线。平均而言,标准剂型(水悬浮剂)的峰值水平低于糖浆混合物。然而,两组中观察到的MPA血浆水平在个体间差异较大,因此无法将这种差异赋予任何统计学意义。

相似文献

1
Medroxyprogesterone acetate plasma levels after a single oral administration of two drug formulations.单次口服两种药物制剂后醋酸甲羟孕酮的血浆水平。
Chemioterapia. 1986 Aug;5(4):237-9.
2
Bioavailability of medroxyprogesterone acetate from three oral dosage formulations.三种口服剂型醋酸甲羟孕酮的生物利用度。
Clin Ther. 1992 Jul-Aug;14(4):544-52.
3
Medroxyprogesterone acetate (MAP) relative bioavailability after single high-dose administration in cancer patients.醋酸甲羟孕酮(MAP)在癌症患者单次大剂量给药后的相对生物利用度。
Cancer Treat Rep. 1982 Dec;66(12):2043-9.
4
The bioavailability of an orally administered medroxyprogesterone acetate suspension.口服醋酸甲羟孕酮混悬液的生物利用度。
Int J Clin Pharmacol Ther Toxicol. 1983 May;21(5):257-9.
5
Effect of injection volume on the bioavailability of sterile medroxyprogesterone acetate suspension.注射体积对无菌醋酸甲羟孕酮混悬液生物利用度的影响。
Clin Pharm. 1983 Sep-Oct;2(5):435-8.
6
Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.氨鲁米特对醋酸甲羟孕酮血浆水平的影响:及其与血清皮质醇的相关性。
Cancer Treat Rep. 1985 Jan;69(1):85-90.
7
MPA at high doses in advanced breast cancer: a statistical evaluation.高剂量甲泼尼龙治疗晚期乳腺癌:一项统计学评估
Chemioterapia. 1986 Jun;5(3):159-63.
8
MPA plasma levels after oral administration in gastrectomized cancer patients during chemotherapy.胃癌患者化疗期间胃切除术后口服给药后的霉酚酸血浆水平。
Chemioterapia. 1985 Jun;4(3):256-9.
9
[High dose medroxyprogesterone acetate in metastatic breast cancer. Comparative clinical, pharmacokinetic and pharmacodynamic data of different forms of administration].[大剂量醋酸甲羟孕酮治疗转移性乳腺癌。不同给药方式的临床、药代动力学和药效学对比数据]
Onkologie. 1982 Aug;5 Suppl:13-6.
10
[The medroxyprogesterone acetate serum level following various medroxyprogesterone acetate dose schedules in gynecologic oncology].
Zentralbl Gynakol. 1988;110(20):1277-82.